Clinical Trial Update: Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of irreversible electroporation for refractory tumors in the liver and pancreas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• Irreversible Electroporation

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Refractory Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN